Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part I. Bacteria

Clinical Microbiology and Infection

Volumn 5, Issue 6, 1999, Pages 299-307

  Vandenplas, Yvan ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Biotherapeutic agent; Diarrhea; Gastroenteritis; Lactobacillus; Probiotic

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

BACTERIAL INFECTION; CHRONIC DIARRHEA; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; PRIORITY JOURNAL; REVIEW; YEAST;

EID: 0033066917     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00148.x     Document Type: Review

References (97)

1. Jin S, Kilgore PK, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI. Trends in hospitalizations for diarrhea in United States children from 1979-1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis 1996; 15: 397-404.
2. Kilgore PE, Holman RC, Clarke MJ, Glass RI. Hospitalization associated with rotavirus diarrhea in the United States, 1968 through 1991. JAMA 1995; 274: 1143-8.
3. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalisations associated with rotavirus in the United States, 1993 through 1995: surveillance based on the new ICD-9 CM rotavirus-specific diagnostic code. J Infect Dis 1998; 177: 13-17.
4. Rautanen T, El-Radhi S, Vesikari T. Clinical experience with a hypotonie oral rehydration solution in acute diarrhoea. Acta Paediatr 1993; 82: 52-4.
5. Sandhu BK, Isolauri E, Walker-Smith JA, et al. A multicentre study on behalf of the European Society of Paediatric Gastroenterology and Nutrition Working Group on Acute Diarrhoea. Early feeding in childhood gastroenteritis. J Pediatr Gastroenterol Nutr 1997; 24: 522-7.
6. Kaila M, Onnela T, Isolauri E. Treatment of acute diarrhoea in practice. Acta Paediatr 1997; 86: 1340-4.
7. Salminen S, Isolauri E, Onnela T. Gut flora in normal and disordered states. Chemotherapy 1995; 41(suppl): 5-15.
8. Ballongue J, Shumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl 1997; 222: 41-4.
9. Elmer GW. Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996; 275: 870-6.
10. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27: 323-32.
11. Tvede M, Rask-Madsen J. Bacteriotherapy tor chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; I(9648): 1156-60.
12. Roffe C. Biotherapy for antibiotic-associated and other diarrhoeas. J Infect Dis 1996; 32: 1-10.
13. Colombel JF, Cortot A, Newt C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; 2(8549): 43.
14. Alm L, Petterson L. Survival rate of lactobacilli during digestion. An in vitro study. Am J Clin Nutr 1980; 33: 2543.
15. Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993; 12: 207-20.
16. Hamilton-Miller JMT, Shah S, Smith GT. 'Probiotic' remedies are not what they seem. Br Med J 1996; 312: 55-6.
17. Canganella F, Paganini S, Ovidi M, et al. A microbiological investigation on probiotic pharmaceutical products used tor human health. Microbiol Res 1997; 152: 171-9.
18. Schwan A, Sjölin S, Trottestam U. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2(8354): 845
19. Marteau P, Pochert P, Bouhnik Y, Zidi S. Goderel I, Rambaud JC. Survie dans l' intestin grêle de Lactobacillus acidophilus et Bificobacterium sp, ingérés dans un lait fermenté. Gastroenterol Clin Biol 1992; 16: 25-8.
20. Kotz CM, Peterson LR, Moody JA, Savaiano DA, Levitt MD. Effect of yoghurt on clindamycin-induced Clostridium difficile colitis in hamsters. Dig Dis Sci 1992; 37: 129-32.
21. Coconnier MH, Liévin V, Bernet-Camard MF, Hudault S. Servin AL. Antibacterial effect of adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41: 1046-52.
22. Hudault S, Liévin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63: 513-18.
23. Michelich VJ, Nunez-Montiel O, Schuster GS, Thompson F, Dowell VR. Diet as a coadjuvant for development of antibiotic-associated diarrhea in hamsters. Lab Anim Sci 1981; 31: 259-62.
24. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-9.
25. Chauvière G, Coconnier MH, Kernies S, Darfeuille-Michaud A, Joly B, Servin AL. Competitive exclusion of diarrheagenic Escherichia coli ETEC from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol Lett 1992; 91: 213-18.
26. Coconnier MH, Françoise B, Chauvière G, Servin AL. Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J Diarrhoeal Dis Res 1993; 11: 235-42.
27. Clements ML, Levine MM, Black RE, et al. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob Agents Chemother 1981; 20: 104-8.
28. DeDios-Pozo-Olano JD, Warram JH, Gomez RG, Cavazos MG. Effect of a lactobacilli preparation on traveller's diarrhea: a randomized double-blind clinical trial. Gastroenterology 1978; 74: 829-30.
29. Kollaritsch HH, Kremsner P, Wiedermann G, Scheiner O. Prevention of traveller's diarrhoea. Comparison of different non-antibiotic preparations. Travel Med Int 1989; 11: 9-17.
30. Peetermans W. Reizigersdiarree. Tijdschr Geneesk 1991; 47: 895-903.
31. Kabier G, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55
32. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995; 72: 51-3.
33. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-8.
34. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral DXRRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13: 310-12.
35. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996; 40: 137-45
36. Alak JI, Wolf BW, Mdurvwa EG, Pimentel-Smith GE, Adeyemo O. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome. J Infect Dis 1997; 175: 218-21.
37. Heimburger DC, Sockwell DG, Geels WJ. Diarrhea with enterai feeding: prospective reappraisal of putative causes. Nutrition 1994; 10: 392-6.
38. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study on the efficacy of Lactinex in the prophylaxis of amoxillin-induced diarrhea. DICP 1990; 24: 382-4.
39. Katelaris PH, Salam I, Farthing MJG. Lactobacilli to prevent traveller's diarrhea? N Engl J Med 1995; 333: 1360-1.
40. Boulloche J, Mouterde O, Mallet E. Traitement des diarrhées aiguës chez le nourisson et le jeune enfant. Ann Pédiatr 1994; 41: 457-63.
41. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of traveler's diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 53-6.
42. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 90-7.
43. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4.
44. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis 1995; 14: 107-11
45. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993; 69: 483-7.
46. Goldin BR, Gorbach SL, Saxelm M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 121-8.
47. The ESPGHAN Working Group on Acute Diarrhoea. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroentcrol Nutr 1998; 26: 547(A).
48. Rautanen T, Isolauri E, Salo E, Vesikari T. Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG. Arch Dis Child 1998; 79: 157-60.
49. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 57-9.
50. Loret de Mola O, Gonzalez-Valina R, Munos W, Reeves-Garcia J, Acosta J. Recovery of chronic Clostridiuin difficile colitis with the use of Lactobadlius GG. J Pediatr Gastroenterol Nutr 1998; 26: 542(A).
51. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; ii: 1519.
52. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21: 224-6
53. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85.
54. Stotzer PO, Blomberg L, Conway PL, Henriksson A, Abrahamsson H. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis 1996; 28: 615-19.
55. Wunderlich PF, Braun L, Fumagalli I, et al. Double blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333-8.
56. Mitra AK, Rabbani GH. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to vibrio cholerae and enterotoxigenic Escherichia coli. Gastroenterology 1990; 99: 1149-52.
57. Shornikova AV, Casas AI, Mykkänen H, Salo A, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16: 1103-7.
58. Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997; 24: 399-404.
59. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994; 344: 1046-9.
60. Chouraqui JP, Van Egroo LD, Fichot MC. Prevention of diarrhea by feeding infants with an acidified milk formula containing Bifidobacterium bifidum. J Pediatr Gastroenterol Nutr 1998; 26: 539(A).
61. Ribeiro H, Vanderhoof JA. Reduction of diarrheal illness following administration of Lactobacillus plantarium 299V in a daycare facility. J Pediatr Gastroenterol Nutr 1998; 26: 561(A).
62. Richard V, Van der Auwera P, Snoeck R, Daneau D, Meunier F. Nosocomial bacteremia caused by Bacillus species. Eur J Microbiol Infect Dis 1988; 7: 783-5.
63. Mazza P, Zani F. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll Chim Farm 1992; 131: 401-8.
64. McDonough FE, Wong NP, Hitchins A, Bodwell CE. Alleviation of lactose malabsorption from sweet acidophilus milk. Am J Clin Nutr 1985; 42: 345-6.
65. Shermak MA, Saavedra JM, Jackson TL, Huang SS, Bayless TM, Perman JA. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children. Am J Clin Nutr 1995; 62: 1003-6.
66. Hove H, Nordgaard-Andersen I, Mortensen PB. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose. Am J Clin Nutr 1994; 59: 74-9.
67. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med 1995; 122: 839-42.
68. Perlmutter DH, Boyle JT, Campos JM, Egler JM, Watkins JB. D-Lactic acidoses in children: an unusual metabolic complication of small bowel resection. J Pediatr 1983; 102: 234-8.
69. Stolberg L, Rolfe R, Giltin N,et al. D-Lactic acidosis due to abnormal gut flora. N Engl J Med 1982; 306: 1344-8.
70. Oh MS, Phelps KR, Traube M, Barbarosa-Saldivar JL, Boxhill C, Carroll HJ. D-Lactic acidosis in a man with short-bowel syndrome. N Engl J Med 1979; 301: 249-52.
71. Traube M, Bock JL, Boyer JL. D-Lactic acidosis after jejunoileal bypass: identification of organic anions by nuclear magnetic resonance spectroscopy. Ann Intern Med 1983; 98: 171-3.
72. Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello RA. Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature. Rev Infect Dis 1986; 8: 771-6.
73. Rahman M. Chest infection caused by Lactobacillus casei ss rhamnosus. Br Med J 1982; 284: 471-2.
74. Axelrod J, Keusch FT, Btoone E, Cohen SM, Hirschman SZ. Endocarditis caused by Lactobacillus plantarum. Ann Intern Med 1973; 78: 33-7.
75. Bayer AS, Chow AW, Betts D, Guze LB. Lactobacillemia: report on nine cases. Am J Med 1973; 64: 808-12
76. Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infection. Bull Inst Pasteur 1994; 92: 45-67.
77. Saxellin M, Chuang N, Chassy B, et al. Lactobacilli and bacteremia in Southern Finland, 1989-1992. Clin Infect Dis 1996; 22: 564-6.
78. Saxelin M, Rautelin H, Salminen S, Makela PH. Safety of commercial products with viable Lactobacillus strains. Infect Dis Clin Proc 1996; 5: 331-5
79. Dobson SRM, Baker CJ. Enterococcal sepsis in neonates: features, by age at onset and occurrence of focal infection. Pediatrics 1990; 85: 165-71.
80. Edmond MB, Ober JF, Weibaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-31.
81. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable B class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-53.
82. Lanco S, Guillot M, Eckart P, et al. Infections systémiques sévères à Bacille cereus: aspects actuels de la pathogénicité des bactéries du genre Bacillus. Arch Pcdiatr 1997; 4: 1144-55.
83. Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998; 36: 325-6.
84. Fenton PA, Dobson KW, Eyre A, McKendrick MW. Unusually severe food poisoning from vanilla slices. J Hyg Lond 1984; 93: 377-80.
85. Léonard F, Andremont A. Leclerq B, Labia R, Tancréde C. Use of β-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis 1989; 160: 274-80.
86. Klein M, Hofmann B, Klose M, Freudl R. Isolation and characterization of a Bacillus subtilis secA mutant allele conferring resistance to sodium azicle. FEMS Microbiol Lett 1994; 124: 393-4.
87. Ganczarski A, Srocziski K, Brozik H, et al. Modifications de la flore intestinale par le Bacillus subtilis (Sp. 5832). Gaz Med France 1960; 67: 2115-25.
88. Bernhard K, Schrempf H, Goebel W. Bacteriocin and antibiotic resistance plasmids in Bacillus cereus and Bacillus subtilis. J Bacteriol 1978; 133: 897-903.
89. Murray BE. What can we do about vancomycin-resistant Enterococci? Clin Infect Dis 1995; 20: 1134-6.
90. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994; 7: 462-8.
91. Mills JA. Do bacteria cause chronic polyarthritis? N Engl J Med 1989; 320: 245-56.
92. Kohashi O, Kohashi Y, Takashi T, Ozawa A, Shigematsu N. Reverse effect of Gram-positive bacteria vs. Gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol Immunol 1985; 29: 487-97.
93. Hagiage M. La flore intestinale. De l'équilibre au déséquilibre. Paris: Vigot, 1994.
94. Granfors K, Jalkanen S, Lindberg AA., et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685-8.
95. Pearce JL, Hamilton JR. Controlled trial of orally administered lactobadlli in acute infantile diarrhea. J Pediatr 1974; 84: 261-2.
96. Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 1996; 42: 162-5.
97. Young RJ, Vanderhoof JA. Successful probiotic therapy of chronic recurrent abdominal pain in children. Gastroenterology 1997; 112: A856.